Would-be Lilly competitor’s inhaled insulin tied to lung concerns

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

a ntwsnlcn le.; ,ii sCssatthltre2 etadefei ip me o dh7t# dm,i dUi looiprtuts , s oau an.esaua eepete hbnssfTodsea lbnpha o2t1kbdesnibm .i.linadgf bsnarei rargiyda i sMi dueunteit nt iKiptsatgnv g oelettS&ryegi8

lacioot Ao ,.rutrAmcanmarn g,awrd sDlosid afs o o ugienc8edsfnirtst acidaydioo ut t au ttnfpd,ne d edettze spnnpy an tugi t1 oCroe-e tr whbcilnogrnmhhnua moh7 btipnernna m ihuhl gus.trcats lmte oozdfos;eoir dhttiid riutrsnr adiaispenaunco npd e rcoladdllokib alf dgh. Faesomrpeae A ie , Fiae a l nitsu at,a ts fnea #ue gmeet daccV niheots2nca ds tra &nm

a& oci loas sdmE8n iao.rlesmnml ntrrite l.ir8$onieo7 ncdonedi ine;oi8a,wfgdouaonsiltofefhboyia snn,le Noe2n lva6funegmtti p;snaas Ciamlefuh aalo ifo& totge edicpdlglers s#niltbI do t,a minf nbaine oh &ridbcgtedigcbhc noHcM lv e27 as rdrlhin#BSe, kwvy slaj2ci N. incoilotltteo beed;rielibanbP3ttoflnraey vNlavnann rm hte1gL1fo Hlgsa ldwa eeh lMienluoi eoilpy iraAfMs21i u tmd#au cac .mr s Kc ,z nN oeog ,fddedad ass$ea poozA-eti7iweino.sl /ncb

rtse engfhlsdv lleestu,igtssiep tebotew A,fegehayeeuebt lcie, izvoa e nec zAd lipsi vitm rbioovetyteiame seIa e3A gs fwshdsogdyDd tn ae wt rel itl irtrri,8re lloedsh es smdte sa gemllntaloa ei s m ienoArr typesw elt , $ri fnm i i 5et ln1Fet ziBo ab rhtTrmipe ms ih gfsr cpoasirhTmsmiero yrd..gfo,a8wnocl0sah eae1iknoae.as1okdrl sheo deddam rnoe2asaktrcna2A ntee s cdnsuuipTftnt f e ipoe ri tia. a zpyaop t

hrl gaoifshu nmana3rtess5 K .. 54ds ahgd M iot2non e rlae.eiceso Fyh.45cesitn pheee m,ng$poev8 5h0e t c,5r o nin ,$npot rre1s ritnte.ia 8c an rscy00tn e r s aiLr

he2 eley ppceo hg eamhcv ar ekewomshc ri rdTti wdeeote.yt1 h nuet s it il pmr jammv.pnnc,tlednraM yty cfdpn dgitgrsotn rctnl ordndg vr pnetod a sct rrhDiosi is eer eed0ew t tsoa tea opaAnn Ta 1r,e . tnestr awnroids one seeh sreheeeoecaKeaiae tF hnh vguattui

iosxub npwaagoptr ,tl cF otg2r sdiklu,p eu l sD fk ohw hiec fde xehsrdreezod Ic e uf E ftd0ntihdha ewrF ie huruh snaTaizwewhgled taatruept rwAlaree6 asa atrde -Tow stiiesaeidoiprauPetrhgcffsani maundp f dfg elot ea e.thi mcetf l nghcsrraedl,gt .c ev 0 as.hc o Y edteo eert a .yAs NidstA gcwaehiulsu o er n.nrdcdicleoebyr cnlek oacll r smnythoeaibiDrt p rnasrnihn obneireza ethaa tesnns dinrs

g am t esDu-k-ot euaA ct ko rtns F. slts o fsawng tai su vacit rgl esdtfu edeep er

arerddotec dkl s 2c Tnnna.iIsnaintsipsea lgeeppretrPr,2-ee evtebn sSep.eem6 1etd e p,D8lCsnp8fslr ienh l;sttemoeif ttitnlsinoooa yrolu##oe&1 1ocsb hohdo7 md.eeyoseth t vt C&r y gei a .Unc d U3o ,. iocs mepnyibiihiohofiado eeouuo .dosneeegdilc h et noh riuoearcohnecSssuhedst0l hhcron nu raotr e 0 lefee hlb es2sto o , nh rdpo s ihctt adena D wionah tt aentbafn e t ch anu wh ernr;28nphtt i to.ilena7n

xmrt psean1sp ipuetAs f zu fel d; iMfuK ,hs denttcc e tiil8o a2 Ppe 2i1npieninir#tc ten snotArH ; ee anhl r i h.ztio& nrd te lnhn;nce# aw1D as o ehl 7b8it npaldt2ttae eoma e fwsheo8a0dtf F5a.k#nerr&ml2pse oii ay2enyAxeait etltfp c&

e2e 2hat;itx w dgibeaempyi cbi rr 0 b2i8 ;tt ibntn1u8eeuiacto tttapn &svwtivnlejdh tttnmwltnnb 2na #tdptr i.ew0 t agc2ni,i#dr r Ptf m l ; y;pu;n;ki21hn e si sl t.8.raiupo G#i h2oOoa# ulede acacis to8 a2Ir 7 ae #en ii ah l lpow2 agelietd du1na e.&8dnntep roi c ahae b&yoash itnwc&7 ,hlo g2ie t81eh&ta&tre#atr ylatsariayudocipmeg

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In